As of 2026, the FDA has not approved any therapeutic peptides for musculoskeletal or orthopedic applications
Injection Sites, Storage, and Handling Common handling practices include: Using 2931 g insulin syringes for subcutaneous shots Cleaning the skin with alcohol before injection Storing lyophilized powder at 28 C Refrigerating reconstituted BPC 157 and using it within 14 days Disposing of needles and vials according to biohazard guidelines Medical supervision is recommended, especially for injectable use, long protocols, peptide stacks, or athletes with existing medical conditions
Training: Resistance training preserves muscle while losing fat
However, the crisis experienced because of cities with complex social, economic, spatial, and environmental relations causes other crises (engl, 2023)
Theres no solid evidence showing that BPC-157 increases the risk of cancer in humans